|

Carvedilol Clinical Trials

9 actively recruiting trials across 3 locations

▲ +1 trial since June 2026

Also known as: Coreg, carvid

Pipeline

Phase 3: 1Phase 4: 5Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • Virginia Commonwealth University1
  • University of Rochester1
  • Taipei Veterans General Hospital, Taiwan1
  • Sherief Abd-Elsalam1
  • SWOG Cancer Research Network1

Indications

Other6 trials

Acute Portal Pressure Reduction by Metformin and Carvedilol Compared to Carvedilol Alone in Cirrhosis.
N/A
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
Phase 2/3
DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
Phase 4
Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC
Phase 4
Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease
Phase 4

Anchorage, Alaska1 trial

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Anchorage Associates in Radiation Medicine

Phase 3

Scottsdale, Arizona1 trial

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

HonorHealth

Phase 4

Richmond, Virginia1 trial

Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan

Virginia Commonwealth University

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.